ADMA Biologics Inc (ADMA) stock news · P/E 22, rev $238.9M
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
This ADMA news page leads with what ADMA Biologics Inc filed — not a scraped headline mill.
No cached 8-K sentence for ADMA yet. We will not pad this page with generic market recap.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ADMA stock page; for the tape open the quote page.
Not investment advice.